Results 41 to 50 of about 86,432 (312)

The death of cost-minimization analysis? [PDF]

, 2001
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Altman, Briggs, Connolly, Connolly, Donaldson, Drummond, Drummond, Freiman, Gold, Kuck, Laska, O'Brien, O'Brien, Robinson, Robinson, Robinson, Robinson, Senn, Stinnett, Stinnett, Tambour, van Hout   +21 more
core   +2 more sources

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Myocardial bridge (MB), common anatomic variant, is generally considered benign, while previous studies have shown associations between MB and various cardiovascular pathologies.
Kozo Okada, Kiyoshi Hibi, Yutaka Ogino, Nobuhiko Maejima, Shinnosuke Kikuchi, Hidekuni Kirigaya, Jin Kirigaya, Ryosuke Sato, Hidefumi Nakahashi, Yugo Minamimoto, Yuichiro Kimura, Eiichi Akiyama, Yasushi Matsuzawa, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Kouichi Tamura, Kazuo Kimura   +17 more
doaj   +1 more source

Patient‐Reported Outcomes in a Multidisciplinary Electrophysiology‐Psychology Ventricular Arrhythmia Clinic

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Ventricular arrhythmias (VAs) and their treatment have been associated with psychological distress and diminished quality of life (QOL).
Uday Sandhu, Andrew T. Nguyen, John Dornblaser, Andrew Gray, Karen Paladino, Charles A Henrikson, Adrienne H. Kovacs, Babak Nazer   +7 more
doaj   +1 more source

Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis

Brazilian Journal of Cardiovascular Surgery
Objective: Implantable cardioverter-defibrillator has become the first-line therapy for prevention of sudden cardiac death. Controversial results still exist regarding the effectiveness of implantable cardioverter-defibrillator (ICD) in non-ischemic ...
Zhenhua Xing, Liang Tang, Chenyang Chen, Jiabing Huang, Zhaowei Zhu, Xinqun Hu   +5 more
doaj   +1 more source

Long‐Term Follow‐Up of Patients With Short QT Syndrome: Clinical Profile and Outcome

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Short QT syndrome (SQTS) is a rare inheritable disease associated with sudden cardiac death. Data on long‐term outcomes of families with SQTS are limited.
Ibrahim El‐Battrawy, Johanna Besler, Volker Liebe, Rainer Schimpf, Erol Tülümen, Boris Rudic, Siegfried Lang, Christian Wolpert, Xiaobo Zhou, Ibrahim Akin, Martin Borggrefe   +10 more
doaj   +1 more source

The ICD in heart failure - time for a rethink? [PDF]

, 2016
No abstract ...
McMurray, John J.V.
core   +1 more source

Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling Study.

JACC Clinical Electrophysiology, 2017
OBJECTIVES This study determined the impact of subcutaneous implantable cardioverter-defibrillator (S-ICD) coil and generator position on defibrillation threshold (DFT).
E. Heist, A. Belalcazar, W. Stahl, T. Brouwer, R. Knops   +4 more
semanticscholar   +1 more source

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2017
Background Optimal timing of implantation of an implantable cardioverter/defibrillator (ICD) after newly diagnosed heart failure is unclear given that late reverse remodelling may occur. We aimed to analyze left ventricular ejection fraction (LVEF) after
D. Duncker, T. Koenig, S. Hohmann, J. Bauersachs, C. Veltmann   +4 more
semanticscholar   +1 more source

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator

JACC: Case Reports, 2023
Electromagnetic interference (EMI) between implantable left ventricular assist devices and cardiac implantable electronic devices has been observed. We demonstrated the first case of EMI between a percutaneous ventricular assist device and an implantable
Kosuke Takahari, MD, Takafumi Oka, MD, PhD, Takayuki Sekihara, MD, Kentaro Ozu, MD, Yasuhiro Akazawa, MD, PhD, Daisuke Nakamura, MD, Isamu Mizote, MD, PhD, Tomohito Ohtani, MD, PhD, Shungo Hikoso, MD, PhD, Yasushi Sakata, MD, PhD   +9 more
doaj   +1 more source

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator [PDF]

, 2018
The trans-venous implantable cardioverter defibrillator (TV-ICD) is effective in treating life-threatening ventricular arrhythmia and reduces mortality in high-risk patients.
Adduci, Carmen, Francia, Pietro, Palano, Francesca   +2 more
core   +2 more sources